Osteoimmunology and Nutritional Science
,
Abstract
LETTER TO THE EDITOR
1. Jones D, Glimcher LH, Aliprantis AO. Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. J Clin Invest. 2011 Jul;121(7):2534-42.
2. Gruber R. Cell biology of osteoimmunology. Wien Med Wochenschr. 2010 Sep;160(17-18):438-45.
3. Geusens P, Lems WF. Osteoimmunology and osteoporosis. Arthritis Res Ther. 2011;13(5):242.
4. Lorenzo J, Horowitz M, Choi Y. Osteoimmunology:interactions of the bone and immune system. Endocr Rev.2008 Jun;29(4):403-40.
5. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007 Apr;7(4):292-304.
6. Lee SH, Kim TS, Choi Y, Lorenzo J. Osteoimmunology:cytokines and the skeletal system. BMB Rep. 2008 Jul 31;41(7):495-510.
7. Tucker KL. Osteoporosis prevention and nutrition. Curr Osteoporos Rep. 2009 Dec;7(4):111-7.
8. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res. 1999 Dec;14(12):2067-78.
9. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic High-Fat Diet Reduces Bone Mineralization in Mice. Journal of Bone and Mineral Research. 2001;16(1):182-8.
10. Orozco P. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol. 2004;19(12):1105-12.
11. Bjersand AJ. Bone changes in hypercholesterolemia.Radiology. 1979 Jan;130(1):101-2.
12. Graham LS, Tintut Y, Parhami F, Kitchen CM, Ivanov Y, Tetradis S, et al. Bone density and hyperlipidemia: the T- lymphocyte connection. J Bone Miner Res. 2010 Nov;25(11):2460-9.
13. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995 Feb 2;332(5):305-11.
14. Xiao Y, Cui J, Li YX, Shi YH, Wang B, Le GW, et al.Dyslipidemic high-fat diet affects adversely bone metabolism in mice associated with impaired antioxidant capacity. Nutrition. 2011 Feb;27(2):214-20.
15. Takeuchi K, Ohta M, Sakao A, Terasawa M. Evaluation of hyperlipidemia, osteoporosis and obesity in pre- and postmenopausal asymptomatic Japanese women. International Journal of Gynecology & Obstetrics. [doi: DOI: 10.1016/S0020-7292(00)84646-9].2000;70(Supplement 4):D137-D.
16. Goldring SR. Inflammatory Mediators as Essential Elements in Bone Remodeling. Calcified Tissue International. 2003;73(2):97-100.
17. Graham LS, Parhami F, Tintut Y, Kitchen CM, Demer LL, Effros RB. Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid- induced bone loss. Clin Immunol. 2009 Nov;133(2):265-75.
18. Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids. 2003 Jun;68(6):373-8.
19. Shibata N, Glass CK. Macrophages, oxysterols and atherosclerosis. Circ J. 2010 Oct;74(10):2045-51.
20. Shouhed D, Kha HT, Richardson JA, Amantea CM, Hahn TJ, Parhami F. Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells. J Cell Biochem. 2005 Aug 15;95(6):1276-83.
| Files | ||
| Issue | Vol 12, No 3 (2013) | |
| Section | Articles | |
| Keywords | ||
| NO Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
